Toggle navigation
Home
Search
Services
Blog
Contact
About
Immunomodulating Graft Rejection by Class II MHC Peptide
Magee, Colm C.
Brigham and Women's Hospital, Boston, MA, United States
Search grants from Colm Magee
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of the IL-1 Receptor in the AKI to CKD transition
TERT Promoter Mutations and Telomerase Reactivation in Cancer Cells
VGM: Vanderbilt Genomic Medicine Training Program
HIV-1 Induction of Intracellular Host Defense Mechanisms
Operational Systems Development - Therapeutics
Recently added grants:
Clinical Protocoal and Data Management
Protocol Review and Monitoring System
Shared Resource Management
Animal Models
Immunogenics and Flow Cytometry
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DK009670-02
Application #
2844021
Study Section
Special Emphasis Panel (ZRG7-SAT (01))
Program Officer
Rankin, Tracy L
Project Start
1999-04-01
Project End
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1998
F32 DK
Immunomodulating Graft Rejection by Class II MHC Peptide
Magee, Colm C. / Brigham and Women's Hospital
NIH 1997
F32 DK
Immunomodulating Graft Rejection by Class II MHC Peptide
Magee, Colm C. / Brigham and Women's Hospital
Comments
Be the first to comment on this grant
